ELISA Kit for Cyclophilin A (CYPA)
SEA979HU
Product group Assays
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Cyclophilin A (CYPA)
- Delivery Days Customer12
- Assay Detection Range1.25-80ng/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Cyclophilin A (CYPA) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle and high ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 0.49ng/mL
- Assay Test PrincipleThe test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Cyclophilin A (CYPA). Standards or samples are then added to the appropriate microtiter ...
- Assay Time3h
- CertificationResearch Use Only
- UNSPSC41116158
References
- Ramachandran S, Anandan V, Kutty VR, et al. Metformin attenuates effects of cyclophilin A on macrophages, reduces lipid uptake and secretion of cytokines by repressing decreased AMPK activity. Clin Sci (Lond). 2018,132(6):719-738. doi: 10.1042/CS20171523Read this paper
- Ramachandran S, Vinitha A, Kartha CC. Cyclophilin A enhances macrophage differentiation and lipid uptake in high glucose conditions: a cellular mechanism for accelerated macro vascular disease in diabetes mellitus. Cardiovasc Diabetol. 2016,15(1):152.Read this paper
- Vinitha A, Kutty VR, Vivekanand A, et al. PPIA rs6850: A > G single-nucleotide polymorphism is associated with raised plasma cyclophilin A levels in patients with coronary artery disease. Mol Cell Biochem. 2016,412(1-2):259-68. doi: 10.1007/s11010-015-2632-7Read this paper
- Tsai SF, Su CW, Wu MJ, et al. Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy: A Cross-Sectional Analysis of Diabetes Mellitus. Medicine (Baltimore). 2015,94(42):e1802. doi: 10.1097/MD.0000000000001802Read this paper
- Kao HW, Lee KW, Chen WL, et al. Cyclophilin A in Ruptured Intracranial Aneurysm: A Prognostic Biomarker. Medicine (Baltimore). 2015,94(39):e1683. doi: 10.1097/MD.0000000000001683Read this paper
- Huang CH, Chang CC, Kuo CL, et al. Decrease in plasma cyclophilin A concentration at 1 month after myocardial infarction predicts better left ventricular performance and synchronicity at 6 months: a pilot study in patients with ST elevation myocardial infarction. Int J Biol Sci. 2015,11(1):38-47. doi: 10.7150/ijbs.10271Read this paper
- Ramachandran S, Venugopal A, Kutty VR, et al. Plasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular disease. Cardiovasc Diabetol. 2014,13:38. doi: 10.1186/1475-2840-13-38Read this paper
- Chang CS, Su SL, Chang CC, et al. Cyclophilin-A: a novel biomarker for untreated male essential hypertension. Biomarkers. 2013,18(8):716-20. doi: 10.3109/1354750X.2013.847122Read this paper
- Seizer P, Schönberger T, Schött M, et al. EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation. Atherosclerosis. 2010,209(1):51-7. doi: 10.1016/j.atherosclerosis.2009.08.029Read this paper

